Ticker Symbol: VTVT
vTv Therapeutics Inc - Class A
$1.56 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001641489
Company Profile
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders, including psoriasis. vTv's development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease (COPD), renal disease, and primary mitochondrial myopathy.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3980 Premier Dr
Website: www.vtvtherapeutics.com
CEO: Stephen Holcombe
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.47
Change:
-$0.02
(
-5.43%)
Days Range: $0.43 - $0.48
Beta: 0.81
52wk. High: $1.05
52wk. Low: $0.40
Ytd. Change -30.45%
50 Day Moving Average: $0.46
200 Day Moving Average: $0.67
Shares Outstanding: 81483600
Valuation
Market Cap: 3.8B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A